Identification and targeting of M-phase progression downstream of HER2 in trastuzumab-sensitive and -resistant breast cancer cell lines.
E. Aubrey Thompson
No relevant relationships to disclose
Brian M. Necela
No relevant relationships to disclose
Jennifer M. Carr
No relevant relationships to disclose
Jennifer M. Kachergus
No relevant relationships to disclose
Daniel Serie
No relevant relationships to disclose
Krishna R. Kalari
No relevant relationships to disclose
Yan W. Asmann
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose